People
Figures converted from Swiss francs at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, percentages, and share counts are unitless and unchanged.
The People
Governance grade: A−. Three founders still own 15% of the company, sit on the board for 2–3 days a week, and have not diluted shareholders by a single share since the 2006 IPO; an independent former FINMA chief and a former AXA P&C CEO chair the audit and risk committees. The grade is held back from "A" by founder voting power that no shareholder can challenge, and by a long-term incentive structure (MCP/ExMCP) whose payouts depend on private-fund returns that outsiders cannot verify until carry crystallises 8–14 years out.
Three founders' stake
Board + Founder Ownership
Net Insider Buying (90d, $m)
Board Independence
The People Running This Company
Partners Group is run by an unusual two-tier structure: an eight-person board that includes the executive chairman and the three founders (who do not have line-management roles but each commit 2–3 days per week), and a separate ten-person Executive Team led by US-based CEO David Layton. Eight people matter for the trust judgment.
David Layton (CEO since 2018, age 50). Joined Partners Group in 2005, ran private equity Americas, became co-CEO with André Frei in 2018, sole CEO from 2021. Layton is the architect of the firm's US push and its move from fund-of-funds origins into direct private equity at scale (now $83bn AUM). He lives in Denver, draws his cash compensation in US dollars, and owns 20,220 vested shares plus 5,203 unvested and 48,120 options — small relative to the founders, but his vested shareholding nearly doubled in 2025 (10,153 → 20,220), evidence of share-purchase behaviour rather than just option exercise.
Steffen Meister (Executive Chairman since 2014, age 55). Mathematician (ETH Zurich), joined PG in 2000, served as CEO 2005–2013, transitioned to chair in 2014. Owns 359,189 shares (≈1.35%) — not founder-scale but ~$353m at year-end 2025 prices. Allocates 3–5 days per week. Chairs the Investment Oversight Committee, so he remains operationally embedded, not a ceremonial chair.
The three founders — Alfred Gantner, Marcel Erni, Urs Wietlisbach (all 1996 vintage). Each owns ≈5% directly, together 15.1%, all are Goldman Sachs alumni, none holds a line-management role. Erni was CIO until 2017; Gantner was CEO 1996–2005, then Chairman 2005–2014; Wietlisbach has always run client-facing strategy. They sit on the Investment Oversight Committee (Erni, Gantner) and Client Oversight Committee (Wietlisbach as chair). They are 57–65 years old and still highly active, but the question of how the board looks once they begin to step down is the single biggest unresolved governance question.
Independent directors worth knowing. Gaëlle Olivier (Lead Independent Director, RAC and OOC chair) — former AXA P&C CEO, Société Générale Asia-Pacific CEO and Group Deputy GM; serious buy-side, derivatives, and operational credentials. Dr. Urban Angehrn (joined May 2025) — former CEO of FINMA (Switzerland's financial regulator, 2021–2023) and former Group CIO of Zurich Insurance; combines regulatory and asset-allocation experience that PG specifically needs as it grows insurance partnerships. Flora Zhao (NCC chair) — 30 years at BP (President Gas Asia) and AES; brings energy infrastructure and Asia-Pacific lens to investment oversight. Anne Lester — 30 years at JP Morgan AM, ex-Head of Retirement Solutions; relevant for PG's evergreen / wealth distribution push.
Quality of independents is unusually high. A sitting Lead Independent Director who ran AXA's global P&C book and a recent Swiss financial regulator chief on RAC are not box-ticking appointments — these are people who can interrogate management on insurance-balance-sheet AUM growth and regulatory exposure, the two dossiers that matter most for PG's next cycle.
What They Get Paid
CEO David Layton was awarded $20.1m for 2025, of which $12.6m actually vested or paid in cash and shares — the gap between the two numbers is the headline tension in this comp plan, and the report itself flags it (the Compensation Report disclosed multi-year realized pay for the first time in 2024). Total Executive Team compensation was $85.0m across 10 people, down 3.3% from $87.9m in 2024 because the equity LTI pool was cut −4% on the back of a Management Fee EBITDA growth miss.
Is pay sensible? Three answers, depending on what you compare against.
Against peers: PG explicitly states its CEO and ExTe total comp falls below the median of US mid-market private-markets managers it benchmarks to (Blackstone, KKR, Apollo, Ares, Carlyle, Brookfield). For a firm with $33.0bn market cap and ~$1.9bn EBITDA, $20m for the CEO is mid-range and below US peers.
Against performance: The 2025 LTI pool fell −4% because the Management Fee EBITDA growth came in at +3% versus a 10% target (a 0.33x quantitative factor on financial performance). The qualitative factor of 1.23x partially offset this. The system functioned as designed — a miss produced a cut, not a flat-line. Pay-for-performance is real but blunt: a 70% miss on the headline financial target produced a 4% pay cut, because the qualitative override is large (50% of the equity LTI pool).
Against what was actually delivered: The realized pay table is more honest. Layton received $12.6m in 2025, dominated by a $7.2m MPP vintage payout (carry from MPP 2018 finally hitting). His MCP carry payout was just $720k; the bulk of his $10.5m MCP grant for 2025 will not hit for 8–14 years and is highly contingent on private-equity exit performance.
The compensation cap is real. ExMCP payouts are capped at 1.20x grant value, and the LTI cap is 8× total base for ExTe and 10× for the CEO. PG also commits to a 3-year freeze on Executive Team total base compensation through the introduction of the new ExMCP. That is meaningfully tighter than US private-markets peers where carry is often uncapped.
Are They Aligned?
This is where Partners Group is uncommonly strong. Founder ownership is large, direct, and unencumbered; insider buying outweighs selling by an order of magnitude over the past 90 days; the firm has not issued a single new share since 2006; and minimum-shareholding rules force at-risk equity onto the executive team.
Ownership and control
The three founders together hold 15.14% directly. With Steffen Meister's 1.35% and other Executive Team holdings, internal ownership is approximately 16.5% — a level that gives the founder bloc a blocking minority on any special resolution requiring a two-thirds quorum (notably amendments to transfer restrictions). They cannot dictate to other shareholders, but no hostile shareholder action can succeed without them. That is a genuine governance feature: a hostile bid would require founder consent.
The founders operate under a formal shareholders' agreement filed with SIX Exchange Regulation, with Gantner acting as their representative.
Insider buying versus selling
Insider activity over the last 90 days shows ≈$38.2m of executive-director purchases against ≈$3.7m of sales — a 10× buy:sell ratio. The buys clustered in March–April 2026 at price levels of $1,003–$1,157, after the share price had fallen ~13% over the same window. This is unusually loud insider conviction. By contrast, in November 2025 there was a clean cluster of sales totalling ~$8.8m at $1,375–$1,448 — the founders/executives were net sellers near the highs and net buyers on weakness, which is the pattern shareholders should want to see.
Dilution and option grants
PG has not issued a single share from conditional capital since the 2006 IPO. Total share count remains 26.7m. All MPP/SPP/MCP payouts have been delivered from treasury (currently 916,865 shares, 3.43% of capital, bought back from market). A capital band approved in 2024 allows up to 2.67m new shares (10% dilution) until May 2029, but it is unused. Conditional capital of 4.005m shares for option grants exists but has remained untapped for 19 years.
Related-party behaviour
The most material related-party item is "waived fees" — the value of fees Partners Group does not charge on board/executive co-investments alongside clients. For 2025 these totalled $19.3m for the eight-person board, dominated by Alfred Gantner ($7.65m), Urs Wietlisbach ($7.20m), and Marcel Erni ($4.36m). This is not pay — it is the dollar value of fee discounts on personal capital these individuals have committed alongside clients (typically 1% of programme size). It indicates the founders are deploying their own capital into PG funds at scale, which is a strong alignment signal in itself, but the fee waivers are large enough that they merit transparency. PG discloses them line-by-line, which is the right standard.
There are no loans outstanding to any director or executive (audited). There are no severance agreements, no golden parachutes, no change-in-control acceleration. Bonus-malus / clawback provisions exist but have never been triggered.
Capital allocation behaviour
PG has paid an uninterrupted, growing dividend for two decades, and its dividend policy commits to a payout ratio target. It has not done a buyback that destroys shareholder count (the 3.43% in treasury is held to deliver LTI awards without dilution). Capital expenditure is essentially zero (it's an asset manager). This is a textbook capital-light, cash-return business; the founder-aligned board has not deviated from that model in 20 years.
Skin-in-the-game scorecard
Skin-in-the-Game Score (out of 10)
Score: 8.5 / 10. Founder ownership is real (~15% direct) and locked under a shareholders' agreement; the executive chairman and CEO own meaningful stakes (~$353m and ~$32m+ respectively at year-end 2025); minimum-shareholding rules force 6× salary for the CEO and 3× for ExTe; insider buying dominates selling 10:1 over recent quarters; no dilution since IPO; no severance shenanigans. Half a point lost because two of ten ExTe members (CFO Joris Gröflin and COO Michael Marquardt, both relatively new) are not yet compliant with their minimum-shareholding hurdles. A full point lost because the MCP/ExMCP plans pay out on private-fund returns whose modelling is opaque to outside investors — alignment exists, but verifiability does not.
Board Quality
Partners Group's board is small (eight), 50% independent, and weighted toward people with operating experience in financial services, asset management, and regulation. The expertise mix is unusually deep for a Swiss mid-cap.
What the board does well. The three committees that police management — RAC, NCC, Operations Oversight — are all chaired by independent directors. The Lead Independent Director (Olivier) chairs the two most important of those (RAC and Operations Oversight) and also sits on NCC. RAC met five times in 2025, with the external auditors attending all five, and meetings averaged 3–3.5 hours. The independent directors collectively dedicate 1–2 days per week. None of them sits on a Partners Group portfolio-company board in a way that compromises independence, though several hold seats on PG's local subsidiary boards (e.g., Lester on the US entity, Olivier on the UK entity, Zhao on Singapore) — this is a feature not a bug for a regulated cross-border firm.
Where it is genuinely independent. The independence test PG itself describes is "limited financial dependence" plus no line-management role. By that standard, the four are clean — none has ever held a senior executive role at PG, none has any business relationship beyond co-investing in PG products on the standard employee-program terms.
Where to push back. The Investment Oversight Committee is chaired by the executive chairman (Meister), with founders Erni and Gantner as members and CIO as non-voting member. Investment risk decisions effectively flow through executive-aligned directors. The board's defence is that the IOC's role is value-creation oversight rather than risk veto — and the RAC, chaired by an independent director, is the formal risk committee. That is defensible, but a sceptical investor should note that the people choosing investments and the people overseeing them have substantial overlap.
Compliance and conduct. Bonus-malus / clawback has never been triggered. No FINMA, SEC, FCA, or MAS enforcement action was disclosed in the 2025 governance report. The 2025 AGM passed the 2024 Compensation Report with 87% approval — a clear pass but down from the 90%+ levels of earlier years and a signal that ISS / Glass Lewis are watching the ExMCP cap and the size of CEO pay.
Net read on the board: independent in the ways that matter (audit, comp, ops chairs are all independent; Lead Independent Director is real), but founder voice on investment oversight is loud and explicit. This is not a board designed to second-guess the founders on what to invest in — it is designed to second-guess management on how it is run. That is appropriate for a 30-year-old founder-led asset manager but worth knowing.
The Verdict
Letter grade: A−.
Strongest positives. Founder ownership of ~15%, directly held under a shareholders' agreement, with each founder owning more in shares than they have ever earned in salary; zero share dilution since IPO 19 years ago; net insider buying of ~$38m versus ~$4m of sales over the last 90 days, including buying on a 13% pullback; independent directors of unusual calibre (former AXA P&C CEO, former FINMA chief, former JP Morgan AM head of retirement, former BP Asia Gas president); compensation cap of 1.2× on the new performance-carry plan and an 8–10× LTI cap to total base; the LTI pool actually fell −4% in a year of weaker EBITDA growth; bonus-malus / clawback exists; no severance, no parachutes, no loans; 87% AGM approval of the comp report.
Real concerns. Founders + executive chairman together hold a blocking minority on any two-thirds vote — there is no path to forcing a strategic change without their consent, which is a feature for long-term holders but a fact for activists. Two of ten ExTe members are not yet compliant with minimum-shareholding rules; the executive chairman's 1.35% is much smaller than the founder stakes, which leaves succession concentrated. The Investment Oversight Committee is dominated by executive-aligned directors. The new ExMCP plan ties a meaningful chunk of CEO pay ($10.5m of $20.1m in 2025) to private-fund returns that crystallise 8–14 years out, which means the headline pay number overstates near-term economic burden but creates long alignment without real-time accountability.
The one thing that would change the grade. Upgrade trigger: a clear, public succession plan for the three founders — naming next-generation partners with explicit timelines for board roles — would move this to A. Downgrade trigger: any meaningful selling by founders Wietlisbach, Erni, or Gantner that takes any of them below 4% would shift the grade to B+; a covenant breach or AGM rejection of the comp report (under 70%) would push it to B.
Bottom line for investors: This is a high-trust governance setup for a Swiss-listed asset manager. The founders eat their own cooking, the independent directors are the right people, and the comp plan recently absorbed shareholder feedback (introducing a 1.2× cap and multi-year realized-pay disclosure). The price you pay is concentrated control and a complex private-fund-linked LTI plan that you have to take partly on trust.